The FINANCIAL -- Anyone 16 and older is now approved to be vaccinated for COVID-19, but researchers hope to open up vaccinations for those under 16 soon. Clinical trials for the Pfizer vaccine with children ages 12–15 have shown promising results, Mayo Clinic notes.…
Read More »The FINANCIAL -- Anyone 16 and older is now approved to be vaccinated for COVID-19, but researchers hope to open up vaccinations for those under 16 soon. Clinical trials for the Pfizer vaccine with children ages 12–15 have shown promising results, Mayo Clinic notes.…
You might be interested in
Older people are likely to be vaccinated regardless of party affiliation. New research from the University of Georgia suggests age and…
SARS-CoV-2 infection can trigger the production of immune molecules that damage cells lining blood vessels in the brain, causing platelets…
The FINANCIAL — COVID-19 was the third leading cause of death in the United States between March 2020 and October…
In the UK, there were 346 deaths involving COVID-19 registered in the week ending 24 June 2022, an increase from…